HOME >> BIOLOGY >> NEWS
For the longest distance runner, that tired feeling may not be due to central fatigue

iology.

Methodology

Nine healthy male subjects (age 41.6 5.9 years; mass 152 15 lbs.; height 5 ft., 9 inches four inches; body fat 10.6 2.6 percent), all regular competitors in running or triathlon events, were enrolled in the study. The maximal twitches for knee extensors (KE) and plantar flexors (PF) were both examined before and after the 40-mile race using a bicycle ergometer. This testing device uses the inertia of a flywheel to provide resistance during both shortening (concentric) and lengthening (eccentric) muscle actions. This measures isometric, concentric, and eccentric muscle actions, assessing strength and velocity of different types of muscle actions.

The first session, when subjects were in a nonfatigued state, was conducted in the week prior to the ultramarathon. The test started with a 10 minute warm-up on the bicycle ergometer. The second session was undertaken in a fatigued state, two minutes after the race, and required 20 minutes on the bicycle ergometer.

During both sessions, the KE and PF were given electrical stimulation to determine muscle contractile measurements. During the test in the nonfatigued stage, the intensity was increased until there was no further increase in the height of the muscle twitch (involuntary contraction) or the amplitude of the M wave (electrically evoked muscle potential). The same stimulus level was used during the fatigued stage of the experiment.

Results

Maximal voluntary contractions and maximal voluntary activation decreased significantly after the ultramarathon (a decline of 30.2 18.0 percent and 27.7 13.0 percent, respectively). Surprisingly, peak twitch increased after the ultramarathon from 15.8 6.3 to 19.7 3.3 Nm) and from 131.9 21.2 to 157.1 35.9 Nm for KE. Also, shorter contraction and half-relaxation times were observed for both muscles. The compound muscle action potentials (M wave) were not significa
'"/>

Contact: Donna Krupa
djkrupa1@aol.com
703-527-7357
American Physiological Society
14-Mar-2002


Page: 1 2 3

Related biology news :

1. ICSI and IVF are safe results from worlds largest, longest running study
2. Yellowstones long-distance travelers in trouble, study says
3. Long-distance command sends human growth hormone into action
4. Action at a distance in the hyperoxic eye
5. Misfiring proteins tied to inflammation and sick feeling of type 2 diabetics
6. Scientists sequence genome of kind of organism central to biospheres carbon cycle
7. Genes may be central to cocaine addiction
8. Newborn lambs central heating system could aid fat busting in humans
9. Visualizing the central dogma
10. A link between thimerosal and the brain: Can vaccines affect central nervous system function?
11. Virginia Bioinformatics Institute central to Regional Center of Excellence

Post Your Comments:
(Date:12/10/2014)... RALEIGH, N.C. , Dec. 9, 2014  Valencell, ... announced it is seeing a staggering demand from its ... demand, the Company revealed, is not solely coming from ... industries as well. "A wearable is only ... a result, accuracy is the ultimate driver in long-term ...
(Date:12/10/2014)... Dec. 9, 2014 CIE San Diego has ... provides the connective tissue that enhances care coordination among ... easily share client-level information; earned a second $1 million ... organizations serving seniors aging in community and; will be ... December 11 th 4-6p. CIE San ...
(Date:12/10/2014)... 2014     ...   Jifflenow, a leading ... for business-to-business (B2B) events, today announced a partnership ... near-field communication (NFC), Bluetooth low energy (BLE), and ... , Jifflenow will integrate its meeting ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3
(Date:12/19/2014)... 18, 2014 iLab Solutions, the global ... of Siri Bryant as the new Director of Institutional ... Core Implementations. These two new leadership positions were created ... by ensuring that iLab continues to meet the needs ... four years, iLab has been deployed at over 450 ...
(Date:12/19/2014)... BURLINGTON, Mass. , Dec. 18, 2014  Decision ... dental biomaterial market will grow moderately through ... implant procedures and growing awareness of dental biomaterials all ... underdeveloped markets such as China ... incomes will bring dental procedures within reach for a ...
(Date:12/17/2014)... December 16, 2014 The Activated ... 2013, which is why IBISWorld updated its original industry ... to benefit from an intensified focus on environmental policy. ... new emission standards for power plants and a range ... to IBISWorld Industry Analyst Sarah Kahn, “a range of ...
(Date:12/17/2014)... 17, 2014 Ipsen Biopharmaceuticals, Inc., ... ADR: IPSEY), today announced that Somatuline® ... Somatuline®) was approved by the U.S. Food and ... neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, ... disease to improve progression-free survival (PFS). , “The ...
Breaking Biology Technology:iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
Cached News: